Skip to main content
SpringerLink
Log in

Toward a molecular understanding of human breast cancer: A hypothesis

  • Hypotheses
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

A rate limiting step in most metastatic breast cancers is the development of unlimited proliferative potential by mammary epithelial cells. We describe mechanisms by which these cells can attain this state. The two independent mortality mechanisms controlling fibroblast senescence and immortalization (M1 and M2) are also found in human mammary epithelial cells. However, although both p53 and Rb are involved in the M1 mechanism of fibroblast cellular senescence, in human mammary epithelial cells only p53 is involved. The M1/M2 mechanisms may be induced by the gradual loss of telomere ends that occur as normal cells divide. Loss of telomere ends may result in genomic instability and in altered gene expression due to heterochromatin changes in subtelomeric regions. Events which can abrogate p53 function are described, as is the current state of knowledge about the function of p53. All these factors are included in a molecular model for the onset of breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Shay JW, Wright WE, Werbin H: Defining the molecular mechanisms of human cell immortalization. Biochim Biophys Acta 1072:1–7, 1991

    Google Scholar 

  2. Hayflick L, Moorhead PS: The serial cultivation of human diploid cell strains. Exp Cell Res 25:585–621, 1961

    Google Scholar 

  3. Hayflick L: The limitedin vitro lifetime of human diploid cell strains. Exp Cell Res 37:614–636, 1965

    Google Scholar 

  4. Hayflick L: The expression of human aging at the cellular level.In Dietz AA (ed) Aging — Its Chemistry. Am Assoc Clin Chem, Washington DC, 1980, pp 227–247

    Google Scholar 

  5. Martin GM: Cellular aging — clonal senescence, a review, part I. Am J Pathol 89:484–511, 1977

    Google Scholar 

  6. Harley CB: Telomere loss: mitotic clock or genetic time bomb? Mutation Res 256:271–282, 1991

    Google Scholar 

  7. Blackburn EH: Telomeres. Trends in Biochem 16:378–381, 1991

    Google Scholar 

  8. Blackburn EH: Structure and function of telomeres. Nature 350:569–573, 1991

    Google Scholar 

  9. Blackburn EH: Telomerase. Annu Rev Biochem 61: 113–129, 1992

    Google Scholar 

  10. Greider CW: Telomeres, telomerase and senescence. Bioessays 12:363–369, 1990

    Google Scholar 

  11. Wright WE, Shay JW: Telomere positional effects and the regulation of senescence. Trends in Genetics 8:193–197, 1992

    Google Scholar 

  12. Cooke HJ, Smith BA: Variability at the telomeres of human X/Y pseudoautosomal region. Cold Spring Harbor Symp Quant Biol 51:213–219, 1986

    Google Scholar 

  13. Morin GB: The human telomere terminal transferase is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 59:521–529, 1989

    Google Scholar 

  14. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC: Telomere reduction in human colorectal carcinoma and with ageing. Nature 346:866–868, 1990

    Google Scholar 

  15. Harley CB, Futcher AB, Greider CW: Telomeres shorten during ageing of human fibroblasts. Nature 345:458–460, 1990

    Google Scholar 

  16. Kipling D, Cooke HJ: Beginning or end? Telomere structure, genetics and biology. Human Mol Gen 1:3–6, 1992

    Google Scholar 

  17. Levy MZ, Allsopp RC, Futcher AB, Greider CW, Harley CB: Telomere end-replication problem and cell aging. J Mol Biol 225:951–960, 1992

    Google Scholar 

  18. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, Greider CW, Harley CB: Telomere length predicts replicative capacity of human fibroblast. Proc Natl Acad Sci USA 89:10114–10118, 1992

    Google Scholar 

  19. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, Bacchetti S: Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 11:1921–1929, 1992

    Google Scholar 

  20. Chang PL, Gunby JL, Tomkins DJ, Mak I, Rosa NE, Mak S: Transformation of human cultured fibroblasts with plasmids containing dominant selection markers and immortalizing potential. Exp Cell Res 167:407–416, 1986

    Google Scholar 

  21. Mayne LV, Priestly A, James MR, Burke JF: Efficient immortalization and morphological transformation of human fibroblasts by transfection with SV40 DNA linked to a dominant marker. Exp Cell Res 162:530–538, 1986

    Google Scholar 

  22. Band V, Zajchowski D, Kulesa V, Sager R: Human papilloma virus DNAs immortalize normal human mammary epithelial cells and reduce their growth requirements. Proc Natl Acad Sci USA 87:463–467, 1990

    Google Scholar 

  23. Woodworth CD, Doniger J, DiPaolo JA: Immortalization of human foreskin keratinocytes by various human papillomavirus DNAs corresponds to their association with cervical carcinoma. J Virol 63:159–164, 1989

    Google Scholar 

  24. White E, Cipriani R: Role of adenovirus E1B protein in transformation: altered organization of intermediate filaments in transformed cells that express the 19-kilodalton protein. Mol Cell Biol 10:120–130, 1990

    Google Scholar 

  25. Stein GH: SV40-transformed human fibroblasts: evidence for cellular aging in precrisis cells. J Cell Physiol 125:36–44, 1985

    Google Scholar 

  26. Girardi AJ, Jensen FC, Koprowski H: SV-40-induced transformation of human diploid cells: crisis and recovery. J Cell Comp Physiol 65:69–84, 1965

    Google Scholar 

  27. Wright WE, Pereira-Smith OM, Shay JW: Reversible cellular senescence: implications for immortalization of normal human diploid fibroblasts. Mol Cell Biol 9:3068–3092, 1989

    Google Scholar 

  28. Shay JW, Pereira-Smith OM, Wright WE: A role for both Rb and p53 in the regulation of human cellular senescence. Exp Cell Res 196:33–39, 1991

    Google Scholar 

  29. Shay JW, Wright WE: Quantitation of the frequency of immortalization of normal human diploid fibroblasts by SV40 large T-antigen. Exp Cell Res 184:109–118, 1989

    Google Scholar 

  30. Shay JW, Wright WE: Both Rb and p53 are potential regulators of human cellular senescence.In Brandi ML, Wright R (eds) Hereditary Tumors. Raven Press, New York, 1991, pp 173–182

    Google Scholar 

  31. Shay JW, West M, Wright WE: Re-expression of senescent markers in de-induced reversibly immortalized cells. Exp Gerontol 27:477–492, 1992

    Google Scholar 

  32. DeCaprio JA, Ludlow JW, Figge J, Shew J-Y, Huang C-M, Lee W-H, Marsilio E, Paucha E, Livingston DM: SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54:275–283, 1988

    Google Scholar 

  33. Linzer DIH, Levine AJ: Characterization of a 54K-dalton cellular SV40 tumor antigen present in SV40 transformed cells and uninfected embryonal carcinoma cells. Cell 17:43–52, 1979

    Google Scholar 

  34. Hara E, Tsurai H, Shinozaki A, Nakada S, Oda K: Cooperative effect of antisense-Rb and antisense-p53 oligomers on the extension of lifespan in human diploid fibroblasts, TIG-1. Biochem Biophys Res Commun 179:528–534, 1991

    Google Scholar 

  35. Rudland PS, Ollerhead G, Barraclough R: Isolation of simian virus 40-transformed human mammary epithelial stem cell lines that can differentiate to myoepithelial-like cells in culture andin vivo. Devel Biol 136:167–180, 1989

    Google Scholar 

  36. Chang SE, Keen J, Lane EB, Taylor-Papadimitriou T: Establishment and characterization of SV40-transformed human breast epithelial cell lines. Cancer Res 42:2040–2053, 1982

    Google Scholar 

  37. Van Der Haegen BA, Shay JW: Immortalization of human mammary epithelial cells by SV40 large T-antigen involves a two step mechanism. In Vitro, Cell Devel Biol (in press, 1993)

  38. Bartek J, Bartkova J, Lalani E-N, Brezina V, Taylor-Papadimitriou J: Selective immortalization of a phenotypically distinct epithelial cell type by microinjection of SV40 into cultured human milk cells. Int J Cancer 45:1105–1112, 1990

    Google Scholar 

  39. Garcia I, Brandt D, Weintraub J, Zhou W, Aapro M: Loss of heterozygosity for the short arm of chromosome 11 (11p15) in human milk epithelial cells immortalized by microinjection of SV40 DNA. Cancer Res 51:294–300, 1991

    Google Scholar 

  40. Bartek J, Bartkova J, Kyprianou N, Lalani E-N, Staskova Z, Shearer M, Chang S, Taylor-Papadimitriou J: Efficient immortalization of luminal cells from human mammary gland by introduction of simian virus 40 large tumor antigen with a recombinant retrovirus. Proc Natl Acad Sci USA 88:3520–3524, 1991

    Google Scholar 

  41. Band V, DeCaprio JA, Delmolino L, Kulesa V, Sager R: Loss of p53 protein in human papillomavirus type 16-immortalized human mammary epithelial cells. J Virol 65:6671–6676, 1991

    Google Scholar 

  42. Halbert CL, Demers GW, Galloway DA: The E7 gene of human papillomavirus 16 is sufficient for immortalization of human epithelial cells. J Virol 65:473–478, 1991

    Google Scholar 

  43. Pereira-Smith OM, Smith JR: Functional SV40 T-antigen is expressed in hybrid cells having finite proliferative potential. Mol Cell Biol 7:1541–1547, 1987

    Google Scholar 

  44. Pereira-Smith OM, Smith JR: Evidence for the recessive nature of cellular immortality. Science 221: 964–966, 1983

    Google Scholar 

  45. Huschtscha LI, Holliday R.: The limited and unlimited growth of SV40 transformed cells from human diploid MRC-5 fibroblasts. J Cell Sci 63:77–99, 1983

    Google Scholar 

  46. Pollock RE: Evaluation and treatment of soft-tissue sarcoma. Cancer Bull 44:268–274, 1992

    Google Scholar 

  47. Shay JW, Werbin H, Funk WD, Wright WE: Cellular and molecular advances in elucidating p53 function. Mut Res 277:163–171, 1992

    Google Scholar 

  48. Vogelstein B, Kinzler KW: p53 function and dysfunction. Cell 70:523–526, 1992

    Google Scholar 

  49. Hinds P, Finlay AJ, Levine AJ: Mutation is required to activate the p53 gene for cooperation with theras oncogene and transformation. J Virol 63:739–746, 1989

    Google Scholar 

  50. Finlay CA, Hinds PW, Tan T-H, Eliyahu D, Oren M, Levine AJ: Activating mutations for transformation by p53 produce a gene product that forms an hsc-p53 complex with an altered half-life. Mol Cell Biol 8:531–539, 1988

    Google Scholar 

  51. Shaulsky G, Ben-Ze'ev A, Rotter V: Subcellular distribution of the p53 protein during the cell cycle of Balb/c 3T3 cells. Oncogene 5:1707–1711, 1990

    Google Scholar 

  52. Sturzbecher HW, Maimets T, Chumaker P, Brain R, Addison C, Simianis V, Rudge K, Philip R, Grumaldi M, Court W, Jenkins JR: p53 interacts with p34cdc2 in mammalian cells: implication for cell cycle control and oncogenesis. Oncogene 5:795–801, 1990

    Google Scholar 

  53. Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancer. Science 253:49–52, 1991

    Google Scholar 

  54. Kessler LG: The relationship between age and incidence of breast cancer. Cancer (Suppl) 69:1896–1903, 1992

    Google Scholar 

  55. Joenje H: Genetic toxicology of oxygen. Mutation Res 19:193–208, 1989

    Google Scholar 

  56. Richter C, Park J-W, Ames BN: Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc Natl Acad Sci USA 85:6465–6467, 1988

    Google Scholar 

  57. Fraga C, Shigenaga MK, Park J-W, Degan P, Ames BN: Oxidative damage to DNA during aging: 8-hydroxy-2'-deoxyguanosine in rat organ DNA and urine. Proc Natl Acad Sci USA 87:4533–4537, 1990

    Google Scholar 

  58. Kasai H, Nishimura S:In Sies H (ed) Oxidative Stress, Oxidants and Antioxidants. Academic Press, New York, 1991, pp 99–116

    Google Scholar 

  59. Lindahl T, Nyberg B: Rate of depurination of native deoxyribonucleic acid. Biochem 1:3610–3618, 1972

    Google Scholar 

  60. Loeb LA, Preston BD: Mutagenesis by apurinic/apyrimidinic sites. Annu Rev Genet 20:201–230, 1986

    Google Scholar 

  61. Jones PA, Buckley JD, Henderson BE, Ross RK, Pike MC: From gene to carcinogen: A rapidly evolving field in molecular epidemiology. Cancer Res 51:3617–3620, 1991

    Google Scholar 

  62. Koeberl DD, Bottema CDK, Ketterling RP, Bridge PJ, Lillicrap DP, Sommer SS: Mutations causing hemophilia B: direct estimate of the underlying rates of spontaneous germ-line transitions, transversions, and deletions in a human gene. Am J Human Genet 47: 202–217, 1990

    Google Scholar 

  63. Fersht AR: Fidelity of replication of phage φ174 DNA by DNA polymerase III holoenzyme: spontaneous mutation by misincorporation. Proc Natl Acad Sci USA 76:4946–4950, 1979

    Google Scholar 

  64. Hibner U, Alberts BM: Fidelity of DNA replication catalyzedin vitro on a natural DNA template by the T4-bacteriophage multi-enzyme complex. Nature 285:300–305, 1980

    Google Scholar 

  65. Kunkel TA, Loeb LA: On the fidelity of DNA replication effect of divalent metal ion activators and dexoyribonucleoside triphosphate pools onin vitro mutagenesis. J Biol Chem 254:5718–5725, 1979

    Google Scholar 

  66. Shaulsky G, Goldfinger A, Ben-Ze'ev A, Rotter V: Involvement of wild-type p53 protein in the cycle requires nuclear localization. Cell Growth Devel 2: 661–667, 1991

    Google Scholar 

  67. Momand J, Zambetti GP, Olson DC, George D, Levine AJ: Themdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237–1245, 1992

    Google Scholar 

  68. Moll UM, Riou G, Levine AJ: Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc Natl Acad Sci USA 89:7262–7266, 1992

    Google Scholar 

  69. Fields S, Jang SK: Presence of a potent transcription activating sequence in the p53 protein. Science 249: 1046–1049, 1990

    Google Scholar 

  70. Raycroft L, Wu HY, Lozano G: Transcriptional activation by wild-type but not mutants of the p53 antioncogene. Science 249:1049–1051, 1990

    Google Scholar 

  71. O'Rourke RW, Miller CW, Kato GJ, Simon KJ, Chen DL, Dang CV, Koeffler HP: A potential transcriptional activation element in the p53 protein. Oncogene 5: 1829–1832, 1990

    Google Scholar 

  72. Kern SE, Kinzler KW, Bruskin A, Jarosz D, Friedman P, Prives C, Vogelstein B: Identification of p53 as sequence-specific DNA-binding protein. Science 252: 1708–1710, 1991

    Google Scholar 

  73. El-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B: Human genomic sequences define a consensus binding site for p53. Nat Genet 1:45–49, 1992

    Google Scholar 

  74. Funk WD, Pak DT, Karas RH, Wright WE, Shay JW: A transcriptionally active DNA-binding site for human p53 protein complexes. Mol Cell Biol 12:2866–2871, 1992

    Google Scholar 

  75. Raycroft L, Schmidt JR, Yoas K, Hao M, Lozano G: Analysis of p53 mutants for transcriptional activity. Mol Cell Biol 11:6067–6074, 1991

    Google Scholar 

  76. Kern SE, Pietenpol JA, Thiagalingam S, Seymour A, Kinzler KW, Vogelstein B: Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 256: 827–829, 1992

    Google Scholar 

  77. Lu X, Park SH, Thompson TC, Lane DP:ras-induced hyperplasia occurs with mutation of p53, but activatedras andmyc together induce carcinoma without p53 mutation. Cell 70:153–161, 1992

    Google Scholar 

  78. Hartwell L: Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell 71:543–546, 1992

    Google Scholar 

  79. Kastan MB, Zhan Q, El-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B, Fornace AJ: A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71:587–597, 1992

    Google Scholar 

  80. Watson JD: Origin of concatameric T4 DNA. Nature New Biol 239:197–201, 1972

    Google Scholar 

  81. Olovnikof AM: A theory of marginotomy. J Theor Biol 41:181–190 1973

    Google Scholar 

  82. Harris CC: Chemical and physical carcinogenesis: Advances and perspectives for the 1990s. Cancer Res (Suppl) 51:5023s–5044s, 1991

    Google Scholar 

  83. Ferguson DJP: An ultrastructural study of mitosis and cytokinesis in normal ‘resting’ human breast. Cell Tissue Res 252:581–587, 1988

    Google Scholar 

  84. Preston-Martin S, Pike MC, Ross RK, Jones PA, Henderson BE: Increased cell division as a cause of cancer. Cancer Res 50:7415–7421, 1990

    Google Scholar 

  85. Stamps AC, Gusterson BA, O'Hare MJ: Are tumours immortal? Eur J Cancer 28A:1495–1500, 1992

    Google Scholar 

  86. Nielsen M, Thomson JL, Primdahl S, Dyreborg U, Andersen JA: Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies. Br J Cancer 56:814–819, 1987

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cell Biology and Neuroscience, The University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, 75235-9039, Dallas, Texas, USA

    Jerry W. Shay, Woodring E. Wright & Harold Werbin

Authors
  1. Jerry W. Shay
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Woodring E. Wright
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Harold Werbin
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shay, J.W., Wright, W.E. & Werbin, H. Toward a molecular understanding of human breast cancer: A hypothesis. Breast Cancer Res Tr 25, 83–94 (1993). https://doi.org/10.1007/BF00662404

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00662404

Key words

Search

Navigation